Physician profile
Greg Bever
NPI 1114366440
$4,485.67
in general payments reported to CMS, 2019-2025
16 companies · $745 in 2025
The $745 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $629 · 2022: $376 · 2023: $2,085 · 2024: $650 · 2025: $745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,480.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $2,191.44 | 2021-2024 | Iluvien, Yutiq |
| Regeneron Healthcare Solutions, INC. | $702.72 | 2021-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $530.81 | 2022-2025 | Ozurdex, Durysta |
| Genentech USA, INC. | $228.12 | 2021-2024 | Vabysmo, Susvimo |
| Astellas Pharma US INC | $141.19 | 2023-2025 | Izervay |
| Coherus Oncology, INC. | $134.08 | 2022-2023 | |
| Regeneron Pharmaceuticals, INC. | $118.26 | 2023 | Eylea |
| Apellis Pharmaceuticals, INC. | $80.83 | 2024-2025 | Syfovre |
| Ani Pharmaceuticals, INC. | $65.06 | 2025 | Purified Cortrophin Gel |
| Allergan, INC. | $64.83 | 2021 | |
| Eyepoint US, INC. | $54.43 | 2021-2024 | |
| Neurotech Pharmaceuticals, INC. | $48.87 | 2025 | |
| Oyster Point Pharma, INC. | $44.50 | 2023-2024 | Tyrvaya |
| Amgen INC. | $35.99 | 2025 | Tepezza |
| Sandoz INC. | $22.52 | 2024 | Cimerli |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $22.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Bever listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.